Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Search ...
VBCN - July 2015 Volume 2, No 2
Predictors of Patient Adherence to Multiple Sclerosis Therapy
By
Rosemary Frei, MSc
Multiple Sclerosis
VBCN - July 2015 Volume 2, No 2
A preliminary analysis of predictors of disease-modifying therapy (DMT) adherence, presented at the American Academy of Neurology 2015 annual meeting, reinforces the notion that patient–provider communication is of primary importance.
Read More
Inhaled Levodopa Provides Rapid Motor Improvements in Patients with Parkinson’s Disease
By
Chase Doyle
Parkinson’s Disease
VBCN - July 2015 Volume 2, No 2
An inhaled formulation of levodopa (CVT-301) eased breakthrough motor symptoms in patients with Parkinson’s disease (PD) between standard levodopa doses in a phase 2 clinical trial.
Read More
Racial Disparities in Daily Activities After Stroke: Why Are Outcomes Worse in African Americans?
By
Chase Doyle
Stroke
VBCN - July 2015 Volume 2, No 2
Racial disparities in poststroke activities of daily living (ADL) limitations are not a result of prestroke activity limitations.
Read More
Sodium Valproate Reduces Pain in Pediatric Patients with Migraine
By
Chase Doyle
Headache Management
VBCN - July 2015 Volume 2, No 2
A retrospective review of pediatric emergency department data showed significant pain reduction when sodium valproate (VPA) was used in the second-line setting for the treatment of adolescent patients with migraine.
Read More
Patient-Reported Outcomes in Secondary-Progressive Multiple Sclerosis
By
Chase Doyle
Multiple Sclerosis
VBCN - July 2015 Volume 2, No 2
With worsening symptoms and increasingly unpredictable attacks, the burden for patients with secondary-progressive multiple sclerosis (MS) is undeniable, and studies have shown that accumulating levels of disability experienced by patients with MS have a direct impact on their quality of life.
Read More
Best Practices in Multiple Sclerosis
By
Chase Doyle
Multiple Sclerosis
VBCN - July 2015 Volume 2, No 2
A pragmatic review of literature has identified best practices for network meta-analyses (NMAs) of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis (RRMS).
Read More
Switching from Other Drugs to Teriflunomide Is Safe and Effective
By
Rosemary Frei, MSc
Multiple Sclerosis
VBCN - July 2015 Volume 2, No 2
A recent analysis of current evidence indicates that physicians can switch patients with relapsing-remitting multiple sclerosis (RRMS) from other disease-modifying therapies (DMTs) to teriflunomide (Aubagio) without worrying about a drop in efficacy or serious adverse events.
Read More
Study Identifies Predictors of Outcomes in Patients with Mild Ischemic Stroke
By
Chase Doyle
Stroke
VBCN - July 2015 Volume 2, No 2
A new retrospective review of patients presenting with acute ischemic stroke has shown additional predictors of outcome independent of traditional assessment tools.
Read More
Brio Neurostimulation System Approved for Reduction of Parkinson’s Disease Symptoms
FDA News
VBCN - July 2015 Volume 2, No 2
The FDA approved the Brio Neurostimulation System, an implantable deep brain stimulation device manufactured by St Jude Medical, St Paul, MN, to help reduce the symptoms of Parkinson’s disease and essential tremor.
Read More
Qudexy XR Now Indicated for Pediatric Patients with Seizures
FDA News
VBCN - July 2015 Volume 2, No 2
The FDA has approved an expanded indication for topiramate extended-release capsules (Qudexy XR; Upsher Smith Laboratories, Inc).
Read More
Page 1 of 3
1
2
3
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to receive the free
VBCN
e‑Newsletter.
I'd like to receive:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.